IGC Pharma, Inc. (IGC) earnings
Quarterly results of IGC Pharma, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
IGC Pharma, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) IGC Pharma, Inc. reported revenue of $265K (-35.7% on the same quarter a year earlier) and a net loss of $2.9M.
Diluted earnings per share were -$0.03.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $265K | -35.7% | -$2.9M | -$0.03 |
| Q1 FY2026 | $317K | +16.5% | -$2.4M | -$0.02 |
| Q2 FY2026 | $191K | -53.6% | -$1.8M | -$0.02 |
| Q1 FY2026 | $328K | +20.6% | -$1.6M | -$0.02 |
| Q4 FY2025 | $330K | - | -$1.2M | -$0.02 |
| Q3 FY2025 | $257K | - | -$1.8M | -$0.02 |
| Q2 FY2025 | $412K | - | -$1.7M | -$0.02 |
| Q1 FY2025 | $272K | - | -$2.4M | -$0.03 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Transition-period annual report 10-KT
- Quarterly report 10-Q
When is IGC Pharma, Inc.'s next earnings date?
IGC Pharma, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were IGC Pharma, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, IGC Pharma, Inc. reported revenue of $265K and a net loss of $2.9M. The figures come from its filing with the SEC.
Is IGC Pharma, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $265K, down 35.7% from $412K in the same quarter a year earlier.
Get an email when IGC reports
Follow IGC and we email you its next results the day they are filed, with the numbers explained.